Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P42345 (
mTOR
)
26,049
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
<i>
Dysembryoplastic neuroepithelial tumour
(
DNT
) is categorized as a benign glioneuronal neoplasm affecting children and young adults with chronic epileptic seizures. It is characterized by predominant intracortical localization and nodular architecture.
Dysembryoplastic neuroepithelial tumour
usually demonstrates a distinctive morphological pattern with a specific glioneuronal element but occasionally, its morphological picture is heterogeneous and unspecific. Thus, considering the morphology of
DNT
, three different histopathological subtypes are distinguished: simple, complex, and non-specific and diffuse. The
DNT
lesions are often related with focal cortical dysplasia (FCD) type IIIb, which is postulated to play a role in epileptogenicity. Moreover, the accompanying inflammation process might be implicated in
DNT
-related epileptogenesis.
Dysembryoplastic neuroepithelial tumour
is generally characterized by favourable prognosis and good results of surgical treatment. The pathogenesis and molecular mechanisms involved in
DNT
development remain uncertain. The main molecular findings are connected with BRAF alterations and activation of RAS/ERK, PI3K/AKT and
mTOR
signalling pathways. The present review summarizes the clinical, histopathological and molecular findings of
DNT
. The classification controversy, morphological heterogeneity and diagnostic problems are also discussed. </i>.
...
PMID:Dysembryoplastic neuroepithelial tumour: insight into the pathology and pathogenesis. 2843 Feb 87